HomeEXECUTIVESJoseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical...

Joseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical Technology and AI Research at Cedars-Sinai

Joseph H. Schwab, MD, MS, an internationally recognized leader in the diagnosis and treatment of complex orthopaedic and spinal oncology conditions, has joined Cedars-Sinai as the new director of Spine Oncology for Orthopaedic Surgery and the director of the Center for Surgical Technology and AI Research.

Joseph Schwab combines extensive experience in translational research and clinical trials with a record of high-quality clinical care. He specializes in the management of benign and malignant bone tumors as well as spinal disorders, including stenoses and myelopathy. His expertise will drive transformative advancements in spine oncology and surgical technology at Cedars-Sinai.

“Dr. Schwab’s visionary leadership and profound impact on orthopaedic surgery make him an invaluable addition to our leadership team,” said Mark Vrahas, MD, chair of Cedars-Sinai Orthopaedics. “His expertise aligns seamlessly with our mission to deliver exceptional patient care and to pioneer new frontiers in orthopaedic medical research.”

Schwab will lead the expansion of the spine oncology program, providing destination expert care for patients with challenging spine disorders. Under his direction, the Center for Surgical Technology and AI Research will foster interdisciplinary surgery discovery as Cedars-Sinai advances the development of innovative AI and predictive algorithmic applications for complex spine and musculoskeletal oncology care.

“I am honored to join Cedars-Sinai and contribute to the advancement of spine oncology and surgical technology,” Schwab said. “Backed by an exceptional team and leading-edge facilities, we are ready to make groundbreaking strides in patient care, research and innovation.”

Schwab comes to Cedars-Sinai from Harvard Medical School, where he served as an associate professor of Orthopaedic Surgery. He also was chief of the Orthopaedic Spine Center, director of Spinal Oncology and co-director of the Stephan L. Harris Center for Chordoma Care at Massachusetts General Hospital. Additionally, he directed the SORG Research Laboratory, the Center for Physical Artificial Intelligence at Mass General and the Mass General Brigham Orthopaedic Registries.

Schwab is joined at Cedars-Sinai by a team of researchers from the SORG Research Laboratory, including mechanical engineer Hamid Ghaednia, PhD, whose research focuses on the development of biomedical devices and wearables using a combination of analytical and machine learning algorithms.

Schwab received his medical degree and a master’s degree in clinical pathology from Chicago Medical School and completed his residency at the Mayo Clinic, followed by fellowships in spine surgery at the Hospital for Special Surgery in New York and the Rizzoli Institute in Bologna, Italy. He also completed a fellowship in orthopaedic oncology at Memorial Sloan Kettering Cancer Center and received a second master’s degree from the Harvard/MIT Clinical Investigator Training Program.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Dr Charles R Gordon was the founding Chairman of the Board for Baylor Scott & White's Texas Spine & Joint Hospital. Over the years the hospital has grown, and majority interest of the hospital was sold to Baylor Scott & White and United Surgical Partners International (USPI).
"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.

By using this website you agree to accept Medical Device News Magazine Privacy Policy